Article Per Year (5 Year)
p-Index From 2021 - 2026
0.61
P-Index
This Author published in this journals
All Journal Jurnal Ilmu Kefarmasian Indonesia PREPOTIF : Jurnal Kesehatan Masyarakat Budapest International Research and Critics Institute-Journal (BIRCI-Journal): Humanities and Social Sciences
Mawaddati Rahmi
Unknown Affiliation
Religion Arts Humanities Biochemistry, Genetics & Molecular Biology Economics, Econometrics & Finance Health Professions Medicine & Pharmacology Public Health Social Sciences

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
Cost Analysis from the Patient's Perspective and Economic Difficulties in Hemodialysis Patients at Fatmawati RSUP Jakarta Mawaddati Rahmi; Yusi Anggriani
Budapest International Research and Critics Institute (BIRCI-Journal): Humanities and Social Sciences Vol 4, No 3 (2021): Budapest International Research and Critics Institute August
Publisher : Budapest International Research and Critics University

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33258/birci.v4i3.2514

Abstract

Chronic kidney disease is a global health problem with an increasing prevalence and incidence of kidney failure, has a poor prognosis and high costs. One way to overcome this high financing problem is of course by doing early treatment and for that, it is necessary to identify the risk factors of the disease. The purpose of this study was to examine the costs from the patient's perspective and the economic hardship experienced by the patient's family. The study used a case control method with a ratio of 1:1, where primary data were obtained through direct interviews with patients and/or their families. Based on the analysis, the average transportation cost required for one time hemodialysis is around Rp.12,000 - Rp.178,750, depending on vehicle type and vehicle mileage. Only 54 out of 100 hemodialysis patients need a companion with an average monthly cost of Rp.2,055,556. The cost of lost productivity per month in the study ranged fromRp.691,964 - Rp.1,942,308, depending on the patient's income. However, only 13% of patients experienced economic difficulties in the form of difficulty paying bills and daily needs. Other economic difficulties such as asking for help to selling assets were experienced by 25% of patients, and this was related to the length of time they underwent hemodialysis.
ANALISIS FAKTOR RISIKO PADA PASIEN HEMODIALISIS DI RS-X di JAKARTA Mawaddati Rahmi; Yusi Anggriani; Prih Sarnianto
PREPOTIF : JURNAL KESEHATAN MASYARAKAT Vol. 5 No. 2 (2021): Oktober 2021
Publisher : Universitas Pahlawan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31004/prepotif.v5i2.2392

Abstract

Penyakit ginjal kronik (PGK) merupakan masalah kesehatan global dengan prevalensi dan biaya yang tinggi. Beberapa faktor pemicu PGK bersifat dapat dirubah, dengan harapan untuk menurunkan risiko terjadinya PGK, dan menurunkan tingkat keparahan PGK yang dialami pasien. Kebanyakan PGK akan mengacu pada kegagalan ginjal, sehingga membutuhkan pembiayaan yang akan semakin tinggi. Salah satu cara untuk mengatasi masalah pembiayaan yang tinggi ini tentunya dengan melakukan penanganan dini dan untuk itu perlu mengidentifikasi faktor risiko dari penyakit tersebut. Tujuan dari penelitian ini adalah untuk untuk mengidentifikasi faktor-faktor risiko gagal ginjal, dimana mengidentifikasi faktor risiko gagal ginjal merupakan salah satu cara untuk mengurangi beban ekonomi yang muncul karena penyakit gagal ginjal. Beberapa faktor risiko dapat diubah, akan tetapi faktor risiko dipengaruhi oleh banyak faktor, dimana faktor risiko pada suatu populasi akan berbeda dari populasi lainnya. Penelitian menggunaan metoda case control dengan perbandingan 1:1, dimana data primer diperoleh melalui wawancara langsung deng pasien dan/atau keluarga pasien. Berdasarkan analisis regresi logistik diperoleh hasil faktor yang berkaitan dengan hemodialisis adalah  umur (OR=17,175, p-value=0,006), riwayat penyakit (OR=1248,87, p-value=0,000), konsumsi obat/jamu dengan efek cespleng (OR=23,2, p-value=0,001), konsumsi air dalam sehari (OR=10,6, p-value=0,004), kebiasaan minum berisiko (OR=19,1, p-value=0,029), sumber air minum (OR=6,24, p-value=0,036), dan konsumsi makanan tinggi garam (OR=0,056, p-value=0,033). Kesimpulan: faktor utama pencetus hemodialisis di RS-X adalah pasien dengan riwayat penyakit seperti diabetes, hipertensi dan kelainan jantung.
Tata Kelola Obat JKN: Peran Badan Penyelenggara Jaminan Sosial Kesehatan (BPJS-K) dalam Belanja Obat Strategis Yusi Anggriani; Nurita Andayani; Mawaddati Rahmi; Rasta Naya Pratita; Prih Sarnianto; Atmiroseva Atmiroseva; Erfan Chandra Nugraha; Citra Jaya
JURNAL ILMU KEFARMASIAN INDONESIA Vol 21 No 1 (2023): JIFI
Publisher : Fakultas Farmasi Universitas Pancasila

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35814/jifi.v21i1.1371

Abstract

The National Health Insurance System (JKN) has social and equity insurance principles aiming participants receive basic health benefits. This raises must-have other requirements for circulated medicine, namely availability and accessibility. Thus, this must meet the elements of safety, efficacy/ benefits, good quality, market availability, and easy accessibility. However, drug shortages problem still occurs and ranks 3rd for BPJS Kesehatan services complaints. This study is to identify opportunities and constraints of BPJS in strategic health purchasing to increase access to JKN medicine . This is a crosssectional study using quantitative and qualitative methods. Quantitative research uses Structural Equation Modelling (SEM), while qualitative uses Focus Group Discussion (FGD). This found the problem roots related to JKN medicine shortages, including limited human resource capabilities, in optimal planning processes, e-purchasing method constraints, e-purchasing system and manual purchases medicine prices differences, medicines ordering long lead time, and in optimal BPJS Kesehatan role as a strategic health purchaser. Therefore, it is to increase BPJS Kesehatan’s role as an active purchaser by making an information system for all medicine use in JKN services, forming a Drugs Advisory Board/JKN drug working group and coordination between policy-making institutions to optimize BPJS Kesehatan role in ensuring JKN medicines access.
Co-Authors Atmiroseva Atmiroseva Citra Jaya Erfan Chandra Nugraha Nurita Andayani Prih Sarnianto Prih Sarnianto Rasta Naya Pratita Yusi Anggriani